205 related articles for article (PubMed ID: 12719624)
1. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease.
García-Sierra F; Ghoshal N; Quinn B; Berry RW; Binder LI
J Alzheimers Dis; 2003 Apr; 5(2):65-77. PubMed ID: 12719624
[TBL] [Abstract][Full Text] [Related]
2. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
[TBL] [Abstract][Full Text] [Related]
3. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
[TBL] [Abstract][Full Text] [Related]
4. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
Combs B; Hamel C; Kanaan NM
Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
[TBL] [Abstract][Full Text] [Related]
5. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
[TBL] [Abstract][Full Text] [Related]
7. Tau, tangles, and Alzheimer's disease.
Binder LI; Guillozet-Bongaarts AL; Garcia-Sierra F; Berry RW
Biochim Biophys Acta; 2005 Jan; 1739(2-3):216-23. PubMed ID: 15615640
[TBL] [Abstract][Full Text] [Related]
8. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.
Jicha GA; Bowser R; Kazam IG; Davies P
J Neurosci Res; 1997 Apr; 48(2):128-32. PubMed ID: 9130141
[TBL] [Abstract][Full Text] [Related]
9. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
[TBL] [Abstract][Full Text] [Related]
10. Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain.
Horta-López PH; Mendoza-Franco G; Rodríguez-Cruz F; Torres-Cruz FM; Hernández-Echeagaray E; Jarero-Basulto JJ; Rícny J; Florán Garduño B; Garcia-Sierra F
Neuroscience; 2023 May; 518():83-100. PubMed ID: 35007692
[TBL] [Abstract][Full Text] [Related]
11. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
[TBL] [Abstract][Full Text] [Related]
12. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease.
Ghoshal N; García-Sierra F; Wuu J; Leurgans S; Bennett DA; Berry RW; Binder LI
Exp Neurol; 2002 Oct; 177(2):475-93. PubMed ID: 12429193
[TBL] [Abstract][Full Text] [Related]
13. Catching tau in the act.
Wong BS; Whiteman M
J Alzheimers Dis; 2003 Apr; 5(2):79-80. PubMed ID: 12719625
[No Abstract] [Full Text] [Related]
14. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.
Liu Q; Smith MA; Avilá J; DeBernardis J; Kansal M; Takeda A; Zhu X; Nunomura A; Honda K; Moreira PI; Oliveira CR; Santos MS; Shimohama S; Aliev G; de la Torre J; Ghanbari HA; Siedlak SL; Harris PL; Sayre LM; Perry G
Free Radic Biol Med; 2005 Mar; 38(6):746-54. PubMed ID: 15721985
[TBL] [Abstract][Full Text] [Related]
16. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
Brici D; Götz J; Nisbet RM
J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.
Basurto-Islas G; Luna-Muñoz J; Guillozet-Bongaarts AL; Binder LI; Mena R; García-Sierra F
J Neuropathol Exp Neurol; 2008 May; 67(5):470-83. PubMed ID: 18431250
[TBL] [Abstract][Full Text] [Related]
18. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
Weaver CL; Espinoza M; Kress Y; Davies P
Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
